| CALPA-IN NF1 |
|
https://doi.org/10.18632/oncotarget.25990
Ikrame Lazar,
and Ze’ev A. Ronai
|
| 33051-33051 |
CpG island hypermethylation go circular (RNA)
CpG island hypermethylation go circular (RNA) |
|
https://doi.org/10.18632/oncotarget.26074
Mihnea P. Dragomir,
and George A. Calin
|
| 33052-33053 |
Checks and balances occur not only in government, but also in biology
Checks and balances occur not only in government, but also in biology |
|
https://doi.org/10.18632/oncotarget.25876
John T. Isaacs
|
| 33054-33055 |
MACROD2 deletions cause impaired PARP1 activity and chromosome instability in colorectal cancer
MACROD2 deletions cause impaired PARP1 activity and chromosome instability in colorectal cancer |
|
https://doi.org/10.18632/oncotarget.25887
Anuratha Sakthianandeswaren,
Marie J. Parsons,
Dmitri Mouradov,
and Oliver M. Sieber
|
| 33056-33058 |
177Lutetium-Dotatate delays decline in quality of life in patients with midgut neuroendocrine tumors
177Lutetium-Dotatate delays decline in quality of life in patients with midgut neuroendocrine tumors |
|
https://doi.org/10.18632/oncotarget.25942
Jonathan Strosberg
|
| 33059-33059 |
Prognostic markers for colorectal cancer
Prognostic markers for colorectal cancer |
|
https://doi.org/10.18632/oncotarget.26012
Helen E.J. Tyrrell,
and David Kerr
|
| 33060-33061 |
Population based germline testing for primary cancer prevention
Population based germline testing for primary cancer prevention |
|
https://doi.org/10.18632/oncotarget.25995
Ranjit Manchanda,
and Rosa Legood
|
| 33062-33063 |
mTORC1/2 inhibition re-sensitizes platinum-resistant ovarian cancer by disrupting selective translation of DNA damage and survival mRNAs
mTORC1/2 inhibition re-sensitizes platinum-resistant ovarian cancer by disrupting selective translation of DNA damage and survival mRNAs |
|
https://doi.org/10.18632/oncotarget.25869
Gizelka David-West,
Amanda Ernlund,
Abhilash Gadi,
and Robert J. Schneider
|
| 33064-33076 |
Distinct urinary glycoprotein signatures in prostate cancer patients
Distinct urinary glycoprotein signatures in prostate cancer patients |
|
https://doi.org/10.18632/oncotarget.26005
Rebeca Kawahara,
Fabio Ortega,
Livia Rosa-Fernandes,
Vanessa Guimarães,
Daniel Quina,
Willian Nahas,
Veit Schwämmle,
Miguel Srougi,
Katia R.M. Leite,
Morten Thaysen-Andersen,
Martin R. Larsen,
and Giuseppe Palmisano
|
| 33077-33097 |
Investigation of novel chemotherapeutics for feline oral squamous cell carcinoma
Investigation of novel chemotherapeutics for feline oral squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.26006
Hunter John Piegols,
Marilia Takada,
Maciej Parys,
Thomas Dexheimer,
and Vilma Yuzbasiyan-Gurkan
|
| 33098-33109 |
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth |
|
https://doi.org/10.18632/oncotarget.26011
Janet K. Parrish,
Tyler S. McCann,
Marybeth Sechler,
Lays M. Sobral,
Wen Hua Ren,
Kenneth L. Jones,
Aik Choon Tan,
and Paul Jedlicka
|
| 33110-33123 |
Fludarabine-resistance associates with ceramide metabolism and leukemia stem cell development in chronic lymphocytic leukemia
Fludarabine-resistance associates with ceramide metabolism and leukemia stem cell development in chronic lymphocytic leukemia |
|
https://doi.org/10.18632/oncotarget.26043
Chunfa Huang,
Yifan Tu,
and Carl E. Freter
|
| 33124-33137 |
Trisenox disrupts MDM2-DAXX-HAUSP complex and activates p53, cell cycle regulation and apoptosis in acute leukemia cells
Trisenox disrupts MDM2-DAXX-HAUSP complex and activates p53, cell cycle regulation and apoptosis in acute leukemia cells |
|
https://doi.org/10.18632/oncotarget.26025
Sanjay Kumar,
Andrea Brown,
and Paul B. Tchounwou
|
| 33138-33148 |
Comprehensive analysis identifying aberrant DNA methylation in rectal mucosa from ulcerative colitis patients with neoplasia
Comprehensive analysis identifying aberrant DNA methylation in rectal mucosa from ulcerative colitis patients with neoplasia |
|
https://doi.org/10.18632/oncotarget.26032
Yuji Toiyama,
Yoshinaga Okugawa,
Satoru Kondo,
Yoshiki Okita,
Toshimitsu Araki,
Kurando Kusunoki,
Motoi Uchino,
Hiroki Ikeuchi,
Seiichi Hirota,
Akira Mitsui,
Kenji Takehana,
Tsutomu Umezawa,
and Masato Kusunoki
|
| 33149-33159 |
Prediction of non-muscle-invasive bladder cancer recurrence by measurement of checkpoint HLAG’s receptor ILT2 on peripheral CD8+ T cells
Prediction of non-muscle-invasive bladder cancer recurrence by measurement of checkpoint HLAG’s receptor ILT2 on peripheral CD8+ T cells |
|
https://doi.org/10.18632/oncotarget.26036
Francois Desgrandchamps,
Joel LeMaoult,
Annabelle Goujon,
Adrien Riviere,
Antonio Rivero-Juarez,
Malika Djouadou,
Amory de Gouvello,
Clement Dumont,
Ching-Lien Wu,
Stephane Culine,
Jerome Verine,
Nathalie Rouas-Freiss,
Christophe Hennequin,
Alexandra Masson-Lecomte,
and Edgardo D. Carosella
|
| 33160-33169 |
Autotaxin-β interaction with the cell surface via syndecan-4 impacts on cancer cell proliferation and metastasis
Autotaxin-β interaction with the cell surface via syndecan-4 impacts on cancer cell proliferation and metastasis |
|
https://doi.org/10.18632/oncotarget.26039
Raphael Leblanc,
Debashish Sahay,
Audrey Houssin,
Irma Machuca-Gayet,
and Olivier Peyruchaud
|
| 33170-33185 |
miR-665 targets c-MYC and HDAC8 to inhibit murine neuroblastoma cell growth
miR-665 targets c-MYC and HDAC8 to inhibit murine neuroblastoma cell growth |
|
https://doi.org/10.18632/oncotarget.26046
Nagindra Prashad
|
| 33186-33201 |
Biochemical and cellular consequences of the antithrombin p.Met1? mutation identified in a severe thrombophilic family
Biochemical and cellular consequences of the antithrombin p.Met1? mutation identified in a severe thrombophilic family |
|
https://doi.org/10.18632/oncotarget.26059
José Navarro-Fernández,
María Eugenia de la Morena-Barrio,
Emma Martínez-Alonso,
Ingunn Dybedal,
Mara Toderici,
Nataliya Bohdan,
Antonia Miñano,
Ketil Heimdal,
Ulrich Abildgaard,
José Ángel Martínez-Menárguez,
Javier Corral,
and Vicente Vicente
|
| 33202-33214 |
Hematopoietic stem cell specific V-ATPase controls breast cancer progression and metastasis via cytotoxic T cells
Hematopoietic stem cell specific V-ATPase controls breast cancer progression and metastasis via cytotoxic T cells |
|
https://doi.org/10.18632/oncotarget.26061
Manoranjan Sahoo,
Gajendra K. Katara,
Mahmood Y. Bilal,
Safaa A. Ibrahim,
Arpita Kulshrestha,
Sara Fleetwood,
Kimiko Suzue,
and Kenneth D. Beaman
|
| 33215-33231 |
Prevalence of MDM2 amplification and coalterations in 523 advanced cancer patients in the MD Anderson phase 1 clinic
Prevalence of MDM2 amplification and coalterations in 523 advanced cancer patients in the MD Anderson phase 1 clinic |
|
https://doi.org/10.18632/oncotarget.26075
Vikas Dembla,
Neeta Somaiah,
Pedro Barata,
Kenneth Hess,
Siqing Fu,
Filip Janku,
Daniel D. Karp,
Aung Naing,
Sarina Anne Piha-Paul,
Vivek Subbiah,
Apostolia M. Tsimberidou,
Kenna Shaw,
Funda Meric-Bernstam,
and David S. Hong
|
| 33232-33243 |
Correction: Antibody targeting TSPAN12/β-catenin signaling in vasoproliferative retinopathy
Correction: Antibody targeting TSPAN12/β-catenin signaling in vasoproliferative retinopathy |
|
https://doi.org/10.18632/oncotarget.26102
Felicitas Bucher,
Martin Friedlander,
and Kyungmoo Yea
|
| 33244-33244 |
